Pfizer declares COVID-19 vaccine is ‘safe’ and ‘effective’ for ages 5 to 11

News 09/20/21, 17:06

A pharmaceutical giant celebrated after its COVID-19 vaccine worked on young minors on Sept. 20. Pfizer-BioNTech claims its low-dose immunization produced positive results among recipients aged between 5 and 11. The clinical trial involved reducing elementary school-aged recipient dosage by two-thirds of the recommended amount for adults. "We are pleased to be ...

First vaccine fatality reported in New Zealand

News 08/30/21, 21:17

New Zealand's health ministry confirmed the nation's first fatal COVID-19 vaccination on Aug. 30. A female patient, whose age was undisclosed, suffered deadly complications from the Pfizer vaccine. The patient developed myocarditis, which caused heart inflammation according to Reuters. "This is the first case in New Zealand where a death in the ...

Heart inflammations higher than expected after COVID vaccine, study finds

U.S. 06/30/21, 16:19

A new reviewed study reports that cases of heart inflammations [myocarditis] presented among army men after receiving the CCP (Chinese Communist Party) mRNA vaccine are "higher than expected." The study involved 23 men with an average age of 25 years who presented with "acute onset of marked chest pain" within four ...

End of content

No more pages to load